[HTML][HTML] COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects

DM Smadja, SJ Mentzer, M Fontenay, MA Laffan… - Angiogenesis, 2021 - Springer
Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) is presenting as a systemic disease associated with …

The potential role of ischaemia–reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and …

DB Kell, E Pretorius - Biochemical Journal, 2022 - portlandpress.com
Ischaemia–reperfusion (I–R) injury, initiated via bursts of reactive oxygen species produced
during the reoxygenation phase following hypoxia, is well known in a variety of acute …

[HTML][HTML] Viscoelastometric testing to assess hemostasis of COVID-19: a systematic review

M Bareille, M Hardy, J Douxfils, S Roullet… - Journal of clinical …, 2021 - mdpi.com
Infection by SARS-CoV-2 is associated with a high risk of thrombosis. The laboratory
documentation of hypercoagulability and impaired fibrinolysis remains a challenge. Our aim …

[HTML][HTML] Immunoinflammatory, thrombohaemostatic, and cardiovascular mechanisms in COVID-19

S Gencer, M Lacy, D Atzler… - Thrombosis and …, 2020 - thieme-connect.com
The global coronavirus disease 2019 (COVID-19) pandemic has deranged the recent
history of humankind, afflicting more than 27 million individuals to date. While the majority of …

Fibrinolysis shutdown in COVID-19: clinical manifestations, molecular mechanisms, and therapeutic implications

JP Meizoso, HB Moore, EE Moore - Journal of the American College of …, 2021 - Elsevier
The COVID-19 pandemic has introduced a global public health threat unparalleled in our
history. The most severe cases are marked by ARDS attributed to microvascular thrombosis …

[HTML][HTML] Immuno-thrombotic complications of COVID-19: implications for timing of surgery and anticoagulation

CM Bunch, EE Moore, HB Moore, MD Neal… - Frontiers in …, 2022 - frontiersin.org
Early in the coronavirus disease 2019 (COVID-19) pandemic, global governing bodies
prioritized transmissibility-based precautions and hospital capacity as the foundation for …

[HTML][HTML] Coagulopathy during COVID-19 infection: a brief review

RM Cunningham, KL Johnson Moore… - Clinical and Experimental …, 2023 - Springer
The COVID-19 pandemic caused by SARS-CoV-2 continues to spread rapidly due to its
virulence and ability to be transmitted by asymptomatic infected persons. If they are present …

[HTML][HTML] The prothrombotic state associated with SARS-CoV-2 infection: pathophysiological aspects

N Semeraro, M Colucci - Mediterranean Journal of Hematology and …, 2021 - ncbi.nlm.nih.gov
Abstract Severe coronavirus disease-2019 (COVID-19) is frequently associated with
microvascular thrombosis, especially in the lung, or macrovascular thrombosis, mainly …

[HTML][HTML] The impact of SARS-CoV-2 infection on blood coagulation and fibrinolytic pathways: a review of prothrombotic changes caused by COVID-19

M Bahraini, A Dorgalaleh - Seminars in Thrombosis and …, 2022 - thieme-connect.com
The cardinal pathology of coronavirus disease 2019 (COVID-19) is a primary infection of
pulmonary tract cells by severe acute respiratory syndrome coronavirus 2, provoking a local …

[HTML][HTML] Fibrinolytic serine proteases, therapeutic serpins and inflammation: fire dancers and firestorms

JR Yaron, L Zhang, Q Guo, SE Haydel… - Frontiers in …, 2021 - frontiersin.org
The making and breaking of clots orchestrated by the thrombotic and thrombolytic serine
protease cascades are critical determinants of morbidity and mortality during infection and …